190 related articles for article (PubMed ID: 21688620)
1. [Pharmacology of preventive and therapeutic drugs for NSAIDs ulcers in the gastrointestinal tract].
Naito Y; Takagi T; Yoshikawa T
Nihon Rinsho; 2011 Jun; 69(6):1007-15. PubMed ID: 21688620
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
Dajani EZ; Agrawal NM
J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
[TBL] [Abstract][Full Text] [Related]
3. Challenges in managing NSAID-associated gastrointestinal tract injury.
Goldstein JL
Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
[TBL] [Abstract][Full Text] [Related]
4. [Points that should be considered for selecting drugs for the prevention and treatment of NSAIDs-related ulcers].
Kinoshita Y; Tamagawa Y
Nihon Rinsho; 2011 Jun; 69(6):1044-8. PubMed ID: 21688625
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and treatment of nonsteroidal anti-inflammatory drugs induced ulcers].
Kobayakawa M; Uemura N
Nihon Rinsho; 2007 Oct; 65(10):1857-61. PubMed ID: 17926536
[TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
7. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
Laine L
Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
[TBL] [Abstract][Full Text] [Related]
8. [Proton pump inhibitor H2 receptor antagonist].
Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
[TBL] [Abstract][Full Text] [Related]
9. Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
Singh G; Triadafilopoulos G
Int J Clin Pract; 2005 Oct; 59(10):1210-7. PubMed ID: 16178990
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
Agrawal NM; Dajani EZ
J Assoc Acad Minor Phys; 1992; 3(4):142-8. PubMed ID: 1392409
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and treatment of NSAIDs-induced small intestinal lesions].
Yoda Y; Umegaki E; Higuchi K
Nihon Rinsho; 2011 Jun; 69(6):1093-7. PubMed ID: 21688634
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of prostaglandin derivatives and mucoprotective drugs in treatment and prevention for NSAIDs-induced ulcer].
Fujikawa Y; Watanabe T; Tominaga K; Fujiwara Y; Sato H; Arakawa T
Nihon Rinsho; 2011 Jun; 69(6):1039-43. PubMed ID: 21688624
[TBL] [Abstract][Full Text] [Related]
13. Acid-NSAID/aspirin interaction in peptic ulcer disease.
Hunt RH; Yuan Y
Dig Dis; 2011; 29(5):465-8. PubMed ID: 22095011
[TBL] [Abstract][Full Text] [Related]
14. Role of acid suppressants in prophylaxis of NSAID damage.
Chan FK; Sung JJ
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic imaging of NSAID ulcers].
Ono S; Kato M; Asaka M; Ono Y; Yokoyama A
Nihon Rinsho; 2007 Oct; 65(10):1792-800. PubMed ID: 17926526
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
Hirschowitz BI
Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
19. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice.
Arora G; Singh G; Triadafilopoulos G
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):725-35. PubMed ID: 19306941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
